Impact of malaria and helminth infections on immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in Tanzania.

Brown J, Baisley K, Kavishe B, Changalucha J, Andreasen A, Mayaud P, Gumodoka B, Kapiga S, Hayes R, Watson-Jones D.

Vaccine 2014;32:611-7.

PMID:24291193

PMCID:PMC3898269

DOI:10.1016/j.vaccine.2013.11.061

Related citation